Two doses of measles vaccine protect almost everyone, usually for life. A small minority still end up without protection, either because the vaccine never took or because their antibodies faded over the years. Unlike flu or COVID, the measles virus doesn’t change to dodge the vaccine, so the problem lies in how a person’s body responded, not in an outdated shot.1AAMCNews. Measles cases are on the rise. Here’s what you need to know For most people in this situation the news is reassuring, and the fix is simple.
The Vaccine Never Took for Some People
About 1 in every 100 people never make protective antibodies, even after two measles doses.2ASM. Measles Vaccination and Infection: Questions and Misconceptions This “never took” failure is thought to explain most cases of vaccinated people who remain susceptible.3PubMed Central. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age
The most common cause is timing. Babies are born with measles antibodies passed from their mother, and these protect them for much of the first year.4PubMed Central. Maternal Antibodies: Clinical Significance, Mechanism of Interference with Immune Responses, and Possible Vaccination Strategies But those borrowed antibodies can neutralize the weakened vaccine virus before the baby’s own immune system learns from it.5NEJM Clinician. Maternal Measles Antibody Decay: At What Age Are Infants Susceptible? That’s why measles vaccine works less well when given before 12 months of age.5NEJM Clinician. Maternal Measles Antibody Decay: At What Age Are Infants Susceptible? Even low leftover maternal antibody levels, too weak to protect the baby, can still block the vaccine.4PubMed Central. Maternal Antibodies: Clinical Significance, Mechanism of Interference with Immune Responses, and Possible Vaccination Strategies In one study, babies given a first dose before about 8.5 months had antibody levels below protective a few years after their 14-month dose.6Vaccine Advisor. Early MMR Vaccination in Infants Reduces Protection, Accelerates Antibody Decay
Those maternal antibodies fade gradually through the first year, so the older a baby is at the first dose, the less likely it is to be blocked. This is why routine schedules in countries where measles is rare place the first dose at around a year or later.
People vaccinated very early, often during outbreaks or before travel, are more likely to be in the never-took group. Public health guidance generally says a dose given before the first birthday shouldn’t count toward the usual series. So an adult with one infant dose plus one later dose may effectively have had only one valid dose, a simple paperwork explanation for a low result.
You can check by looking at childhood records, school forms or a parent’s vaccine booklet, which often list the date of each dose. Compare the first dose date with your birth date to see whether it fell before your first birthday. If you can’t find records, a blood test or simply another dose are both acceptable routes.
Missing the response to one vaccine reflects timing or chance, not a weak immune system. By the time you get another dose as an older child or adult, the maternal antibodies are long gone, so the vaccine has a fair chance to work this time.
Protection Can Fade Slowly Over Decades
Waning is real but slow. Only about 1% to 2% of people lose protective measles antibodies per decade.7PubMed Central. Heterogeneity and longevity of antibody memory to viruses and vaccines Still, vaccine-made antibodies fade faster than those left by catching measles, which tend to last a lifetime.8PubMed Central. Comparative Analysis of Long-Term Measles Immune Response After Natural Infection and Routine Vaccination in China In one Italian group, vaccinated people lost detectable antibodies about four times as often as those who’d had the disease.9PubMed Central. Long-term immunogenicity after measles vaccine vs. wild infection: an Italian retrospective cohort study In one Chinese study of children vaccinated at 8 and 18 months, antibody levels were estimated to drop below the protective level around age 16.8PubMed Central. Comparative Analysis of Long-Term Measles Immune Response After Natural Infection and Routine Vaccination in China
The fading shows up in outbreaks. In England, breakthrough infections are increasingly common in twice-vaccinated people aged 15 and older.10PubMed. Long-term waning of vaccine-induced immunity to measles in England: a mathematical modelling study In the Netherlands, adults aged 20 to 34 had lower immunity than young children.11Epidemiology & Infection. High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands Even so, the vaccine still protects strongly for decades, and most spread comes from unvaccinated people.10PubMed. Long-term waning of vaccine-induced immunity to measles in England: a mathematical modelling study
Adults may be hit harder because children vaccinated recently are closest to their last immune boost, while adults may be decades past their last dose. When measles circulates widely, vaccinated people may get quietly re-exposed and have their antibodies boosted without getting sick.12PubMed. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa With measles now rare in many countries, those top-ups no longer arrive, which may help explain fading in adults.
A lower antibody level doesn’t switch protection off at a fixed moment. Protection declines along a spectrum, and many people with low levels would still resist infection. If measles is rare where you live, your chance of exposure is small, though it rises with travel or work in healthcare, which is why those groups are often asked to test. For you personally, the practical answer is the same whether your protection faded or never took: another dose.
Other Reasons the Vaccine May Not Have Worked
Genes play a part. Certain inherited immune-system gene types are linked with lower measles antibody responses,13PubMed Central. The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches and several genes affecting antibody responses to the MMR vaccine have been confirmed in repeated studies.14PubMed Central. Genetics and measles, mumps and rubella vaccine response in childhood and adolescence—A systematic review These gene types are inherited, so a weak response isn’t something you can change, but a further dose still gives the immune system another chance. There’s no routine test for this, so the practical approach is to check antibody levels and add a dose if they are low.
Chemotherapy can erase earlier protection. Childhood cancer survivors often lose measles immunity after chemotherapy,15PubMed Central. Loss of measles, mumps, and rubella immunity in pediatric cancer survivors following chemotherapy because it wipes out the immune cells that hold long-term memory of vaccines.15PubMed Central. Loss of measles, mumps, and rubella immunity in pediatric cancer survivors following chemotherapy Survivors and other people with weakened immunity usually need a re-vaccination plan from their doctor. Timing depends on how far the immune system has recovered, and live vaccines such as MMR aren’t suitable while immunity is still severely weakened, so your treating team needs to approve it.
Vaccine handling matters too. Measles vaccine is a live virus that must be kept between 2 and 8°C and away from light.16Journal of Food and Drug Analysis. The relationship between the cold chain system and vaccine potency in Taiwan: (I) Live measles vaccine and MMR vaccine Power failures and poor handling have made many doses weaker, especially in hot countries with unreliable refrigeration.17PubMed. Live viral vaccine potency: an index for assessing the cold chain system In one Nigerian region, about three quarters of stored doses tested were weaker than they should be.18African Journal of Clinical and Experimental Microbiology. Evaluation of measles vaccine cold chain in Lagos State, Nigeria Mixing mistakes, such as using the wrong liquid, can make a dose useless.19PubMed Central. Vaccine-Related Errors in Reconstitution in South Korea: A National Physicians’ and Nurses’ Survey You can’t check how your own dose was handled, so a blood test or an extra dose settles the question.
Some suspected factors don’t hold up. Studies disagree on whether giving vitamin A with the vaccine helps or hurts the response.20PubMed. Enhancement in seroconversion to measles vaccine with simultaneous administration of vitamin A in 9-months-old Indian infants Body weight was not linked to losing measles protection in one study,21PubMed Central. Body Mass Index and Antibody Persistence after Measles, Mumps, Rubella and Hepatitis B Vaccinations and getting a nasal flu vaccine at the same visit didn’t weaken the MMR response.22Pediatrics. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
What a Negative Immunity Test Really Means
Your report may say “seronegative” or show a low “titer.” Seronegative means the test didn’t find measles antibodies above the level it can reliably detect. A titer is a measure of how much antibody is in your blood, and a low one means the amount is below the cutoff the lab uses. Labs use somewhat different cutoffs, so the wording on your report may vary.
Antibodies aren’t the whole immune picture. Vaccinated people with no detectable antibodies can still have immune cells that recognize measles.23PubMed Central. Frequency of Measles Virus-Specific CD4+ and CD8+ T Cells in Subjects Seronegative or Highly Seropositive for Measles Vaccine After a booster, immune-cell responses may last better than antibody levels in some people.24PubMed. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination But ordinary labs can’t test for those cells, so a negative result is acted on as no protection. Workplaces and schools need a simple, checkable standard, so it’s a cautious rule for paperwork, not a statement that you’re certain to catch measles.
Results are often reported as positive, negative or equivocal. Equivocal usually counts as not immune for job and school rules. Check whether the employer or school will accept documented two doses instead of a test, since some take records. A borderline result usually doesn’t need repeating; getting another dose is generally simpler.
You’re at risk only if you’re exposed, and breakthrough cases in vaccinated people tend to be milder and less contagious. If you are exposed, contact a doctor promptly, because a dose within three days of exposure can help, and people who can’t have the vaccine may be offered other protection.
Getting Another Dose
A third dose usually works. Healthcare workers who had no measles antibodies after two doses saw their levels rise within 4 weeks of a third dose.25PubMed. The third dose of measles-containing vaccine induces robust immune responses against measles in young seronegative healthcare workers who had previous two-dose measles vaccination A year later, about 17 of 18 still had medium or high antibody levels.25PubMed. The third dose of measles-containing vaccine induces robust immune responses against measles in young seronegative healthcare workers who had previous two-dose measles vaccination The third dose also strengthened immune-cell defenses,25PubMed. The third dose of measles-containing vaccine induces robust immune responses against measles in young seronegative healthcare workers who had previous two-dose measles vaccination and antibodies after a third MMR dose decline more slowly than after the second.26PubMed Central. Dynamics of the Antibody Response After a Third Dose of Measles-Mumps-Rubella Vaccine Indicate a Slower Decline Compared With a Second Dose
Adults without proof of immunity are usually advised to get one dose, or two for healthcare workers, students and travelers. An extra MMR dose does no harm to someone already immune. If your job or school requires proof of immunity, getting the shot is often quicker than retesting. MMR isn’t given during pregnancy or to people with severely weakened immunity, so tell your provider if either applies.
In many places adults can get MMR at a pharmacy or clinic without a prescription, though rules differ by location, so check before you go. Typical side effects are a sore arm, a mild fever, or a mild rash that may appear a week or two afterward. Avoid becoming pregnant for one month after the shot, since MMR is a live vaccine. Keep a written or digital record of the date. If you stay negative after extra doses, talk with a doctor about options, since a few people remain without detectable antibodies.

